Posters should provide examples of good practice or innovation in diabetes or obesity care within the primary care setting, highlighting work that is of relevance and, ideally, practical significance to other primary care teams. Accepted posters will be displayed in the exhibition hall during the conference and will be judged by the PCDO Society Committee. An award will be presented for the entry that reflects the best contribution to diabetes and obesity within the primary care setting.
Entries are also open for the Roger Gadsby Award recognising an outstanding audit in primary care diabetes or weight management, with a cash prize of £500 for the winner. See below for more information about the entry requirements for this award.
Click the red button above for online poster submission form for the 22nd National Conference of the PCDO Society. Your abstract will be anonymously peer reviewed and you will receive confirmation of acceptance or non-acceptance by early October 2026.
Read the poster abstracts from the 2025 conference.
Entry process and requirements
Entries are invited in the form of a titled abstract of no more than 250 words, which should include the following sections:
- Aims or objectives
- Methods
- Results
- Conclusions or summary
Please contact the events team at [email protected] if you have any questions or require further information.
Enter your poster for the Roger Gadsby Award
For your chance to win the £500 prize, enter a poster describing your primary care diabetes or obesity audit.
An audit is a proven method of quality improvement, giving practices a systemic way to look at what they should be doing, what they are doing and how to make improvements to benefit patient care. When deciding what to audit, there are a few things to consider:
- The diabetes- or obesity-related condition being audited should affect large numbers of people.
- There should be an evidence base for the condition and the interventions being audited.
- At baseline there should ideally be variations in care.
- The audit cycle should include data collection at baseline, the intervention or change in practice, and re-audit after a pre-agreed time to measure change.
Entries must be made electronically by 17:30 on Friday 28th August 2026.
Click here to submit your poster for the 22nd National Conference of the PCDO Society. Your abstract will be anonymously peer reviewed and you will receive confirmation of acceptance or non-acceptance by early October 2026. Abstracts of accepted posters will be published in a special supplement of Diabetes & Primary Care.
Entry process and requirements
Entries are invited in the form of a titled abstract of no more than 250 words, which should include the following sections:
- Aims or objectives: What is the objective of the audit?
- Methods: Criteria, standard(s), target(s) and exception(s) and the time between baseline and re-audit.
- Results: The baseline and re-audit results.
- Conclusion: What improvements have been achieved?
Please contact the events team at [email protected] if you have any questions or require further information.
Diabetes &
Primary Care
Issue:
Early View
PCDO Society National Conference 2026: Request for poster abstracts
Posters should provide examples of good practice or innovation in diabetes or obesity care within the primary care setting, highlighting work that is of relevance and, ideally, practical significance to other primary care teams. Accepted posters will be displayed in the exhibition hall during the conference and will be judged by the PCDO Society Committee. An award will be presented for the entry that reflects the best contribution to diabetes and obesity within the primary care setting.
Entries are also open for the Roger Gadsby Award recognising an outstanding audit in primary care diabetes or weight management, with a cash prize of £500 for the winner. See below for more information about the entry requirements for this award.
Click the red button above for online poster submission form for the 22nd National Conference of the PCDO Society. Your abstract will be anonymously peer reviewed and you will receive confirmation of acceptance or non-acceptance by early October 2026.
Read the poster abstracts from the 2025 conference.
Entry process and requirements
Entries are invited in the form of a titled abstract of no more than 250 words, which should include the following sections:
Please contact the events team at [email protected] if you have any questions or require further information.
Enter your poster for the Roger Gadsby Award
For your chance to win the £500 prize, enter a poster describing your primary care diabetes or obesity audit.
An audit is a proven method of quality improvement, giving practices a systemic way to look at what they should be doing, what they are doing and how to make improvements to benefit patient care. When deciding what to audit, there are a few things to consider:
Entries must be made electronically by 17:30 on Friday 28th August 2026.
Click here to submit your poster for the 22nd National Conference of the PCDO Society. Your abstract will be anonymously peer reviewed and you will receive confirmation of acceptance or non-acceptance by early October 2026. Abstracts of accepted posters will be published in a special supplement of Diabetes & Primary Care.
Entry process and requirements
Entries are invited in the form of a titled abstract of no more than 250 words, which should include the following sections:
Please contact the events team at [email protected] if you have any questions or require further information.
Diabetes Distilled: Greater reductions in HbA1c ACHIEVEd with orforglipron versus oral semaglutide 14 mg
Prescribing cascades and people living with type 2 diabetes
Supporting adherence in diabetes care
PCDO Society National Conference 2026: Request for poster abstracts
Diabetes Distilled: Weight regain after stopping newer weight management drugs is faster than anticipated
Development of educational resources for patients and clinicians on injectable therapies with cardiovascular benefits
Editorial: A major change to NICE type 2 diabetes guidance
Greater efficacy at the cost of more adverse events in this developmental oral GLP-1 receptor agonist.
2 Apr 2026
This illustrative case study describes an inadvertent "prescribing cascade", and the actions taken to reduce the resulting polypharmacy and side effects.
30 Mar 2026
The importance of medication adherence, and how to assess and support it.
26 Mar 2026
Weight returns to baseline levels an estimated 1.5 years after stopping semaglutide or tirzepatide.
23 Mar 2026